A unified data and analytics foundation for modern life sciences.
DG BioTech LLC is a biotechnology and data science company specializing in integrated bioinformatics, AI analytics, and genomic data solutions designed to advance drug discovery, clinical trial design, and pharmacovigilance.
Our company was founded with a core belief: that modern therapeutics require deeper, more integrated, and more intelligent data capabilities than ever before. To meet this need, we combine computational biology, AI, and clinical domain expertise to empower organizations across the biotech and pharmaceutical ecosystem.
Our specialized areas center on drug safety physician and medical monitor work, and we provide support in clinical trials for all phases and post-marketed settings using various EDCs and safety databases. Our pharmacovigilance tools enable real-time safety analytics, signal detection, and continuous monitoring of post-market data to enhance patient protection.
We serve biopharmaceutical companies, biotechnology startups, academic research institutions, CROs, and clinical organizations seeking to modernize their R&D workflows. Through collaborative partnerships, DG BioTech helps clients overcome data bottlenecks, reduce development timelines, and improve the quality and reproducibility of scientific insights.
Our technology approach is built on scalability, scientific integrity, and innovation. We develop modular workflows that integrate seamlessly with existing infrastructures, support regulatory requirements, and evolve as clients' analytical needs grow.
By leveraging state-of-the-art analytics and predictive modeling, we enable pharmaceutical and life sciences organizations to enhance drug safety monitoring and accelerate time-to-market for novel therapeutics. Our solutions support every stage of the drug development lifecycle—from early discovery to post-market surveillance—helping partners make data-driven decisions with confidence and precision.